Blood and Human Physiology
Blood
Components of Blood
Blood consists of living and non-living components.
The living component consists of three types of cells.
The non-living component is the plasma.
Plasma Constituents
Plasma Constituent and Function:
Water: Serves as a solvent and medium for transporting materials.
Albumin: Maintains osmotic pressure and transports substances.
Gamma Globulins: Are antibodies that play a role in immune response.
Fibrinogen: Involved in blood clotting.
Nutrients and Wastes: Transport of nutrients and metabolic waste.
Salts: Electrolyte balance.
Gases: Transport of oxygen and carbon dioxide.
Role of Blood Cells
Erythrocytes (Red Blood Cells):
Carry oxygen from the lungs to body tissues.
Contain hemoglobin, an oxygen-binding protein.
Leukocytes (White Blood Cells):
Five different types divided into two categories: Granulocytes and Agranulocytes.
Granulocytes:
Neutrophil:
A granulocytic WBC.
Functions to phagocytize bacteria.
Increased numbers indicate a bacterial infection.
Eosinophil:
A granulocytic WBC involved in allergy and parasitic worm destruction.
Has red cytoplasmic granules.
Basophil:
A granulocytic WBC involved in inflammation.
Contains blue cytoplasmic granules filled with histamine.
Agranulocytes:
Lymphocyte:
An agranulocytic WBC involved in immunity.
B Lymphocytes: Produce antibodies.
T Lymphocytes: Directly attack foreign cells.
Monocyte:
An agranulocytic WBC functioning in phagocytosis of bacteria in long-standing infections.
The largest leukocyte.
Platelets (Thrombocytes):
Cytoplasmic fragments of a larger cell, the megakaryocyte.
Functions in hemostasis (stopping bleeding).
Hematopoiesis
The process of blood cell formation.
Occurs in red bone marrow from stem cells called hemocytoblasts.
Differentiation to:
Common Myeloid Progenitor yields:
Erythrocytes
Platelets
Basophils
Neutrophils
Eosinophils
Common Lymphoid Progenitor yields:
T Lymphocytes
B Lymphocytes
Erythropoiesis
The formation of red blood cells occurs in red bone marrow.
From hemocytoblast to reticulocyte maturity.
Reticulocyte Count: A measurement indicating the level of erythropoiesis occurring.
Erythropoietin:
A hormone released from the kidney in response to low blood pO₂.
Stimulates erythropoiesis.
Key factors:
Hypoxemia: Inadequate oxygen transport in blood.
Stimulates increased RBC count and accelerated erythropoiesis.
Conditions of Low pO₂:
Low RBC numbers (anemia).
High altitude due to lower atmospheric pressure.
Athletes: Use high-altitude simulation tents to induce increased erythropoiesis and enhance oxygen capacity.
Life History of Red Blood Cells
RBCs lack a nucleus and do not carry out mitosis.
Produced in red bone marrow (erythropoiesis), with a lifespan of approximately 120 days.
Destruction occurs in small capillaries of the spleen and liver.
Breakdown of Hemoglobin
Iron from heme is recycled.
Globin's amino acids are also recycled.
Porphyrin Ring Breakdown
The porphyrin ring is converted to bilirubin, which is lipid-soluble.
Bilirubin is transported to the liver, modified with glucuronic acid, forming conjugated bilirubin (water-soluble) which is expelled with bile into the intestines and exits with stool.
Blood Types
Antigens (Agglutinogens): Present on RBC membranes and act as 'nametags.'
Antibodies (Agglutinins): Present in plasma; will destroy cells with non-self antigens.
Types: A, B, AB, O blood types.
Rh System:
Rh+: Possesses the Rh antigen.
Rh-: Lacks the Rh antigen; may produce antibodies against Rh.
Risks occur when an Rh- mother is pregnant with an Rh+ baby, leading to erythroblastosis fetalis (hemolytic disease of the newborn).
Hemostasis
Defined as the stoppage of bleeding, comprising three phases:
Vasospasm: Reflexive narrowing of the blood vessels, mediated by serotonin; reduces blood loss.
Platelet Plug Formation: Platelets adhere to exposed collagen fibers, stimulated by ADP and Thromboxane A2, leading to further platelet aggregation.
Coagulation (Clotting): Involves intrinsic and extrinsic pathways that rely on calcium ($Ca^{2+}$) and clotting factors generated by the liver, with Vitamin K supporting the formation.
Pathways of Coagulation
Intrinsic Pathway:
Occurs in 3-6 minutes from damage to the blood vessel wall, mainly stimulated by the platelet plug.
Involves clotting factors including XII, XI, IX, VIII, and X.
Extrinsic Pathway:
Occurs in 15 seconds following damage to both the vessel wall and surrounding tissues.
Involves tissue thromboplastin, VII, and X.
Summary of Coagulation
Clots form through a meshwork of fibrin trapping blood cells and are initiated by thrombin.
Clot retraction occurs as the clot shrinks, bringing vessel edges closer, facilitating repair by PDGF secreted by platelets.
Dissolution of Clot
TPA (Tissue Plasminogen Activator): Released by healed endothelial cells, leading to the activation of plasmin, which dissolves the clot.
Risks of Clots
Potential dangers from clots include thrombi (stationary clots) and emboli (travelling clots), leading to conditions such as strokes, heart attacks, or pulmonary emboli, which may be life-threatening.
Conditions Affecting Clot Formation
Clots may form due to conditions such as:
Atherosclerosis (rough tissue triggering clot formation).
Blood stasis (pooling which activates clotting factors).
Inhibition of Clot Formation
Aspirin: Reduces thromboxane A2 to inhibit platelet plug formation.
Antithrombin III: Binds and inactivates thrombin, inhibiting clot formation.
Heparin: Increases antithrombin III activity, also preventing clot formation.